MX2013000002A - Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. - Google Patents

Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.

Info

Publication number
MX2013000002A
MX2013000002A MX2013000002A MX2013000002A MX2013000002A MX 2013000002 A MX2013000002 A MX 2013000002A MX 2013000002 A MX2013000002 A MX 2013000002A MX 2013000002 A MX2013000002 A MX 2013000002A MX 2013000002 A MX2013000002 A MX 2013000002A
Authority
MX
Mexico
Prior art keywords
array
measurement
aperture
reference beam
return
Prior art date
Application number
MX2013000002A
Other languages
English (en)
Inventor
Anu Mahashabde
Jiaxiang Tsao
Original Assignee
Teva Womens Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45372075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013000002(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Womens Health Inc filed Critical Teva Womens Health Inc
Priority claimed from PCT/US2001/041444 external-priority patent/WO2002010831A2/en
Publication of MX2013000002A publication Critical patent/MX2013000002A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/48—Devices for preventing wetting or pollution of the bed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Abstract

La presente invención se refiere a un método de tratamiento de una condición patológica asociada con una vejiga hiperactiva, que comprende la administración de una hembra un dispositivo intravaginal, que comprende: (a) una primera matriz anular que comprende una cavidad y una pared de cavidad, en donde la cavidad tiene un espesor uniforme, y en donde la pared de la cavidad abarca la cavidad; y (b) una segunda matriz que comprende un agente anticolinégico ubicado en la cavidad.
MX2013000002A 2001-07-27 2001-07-27 Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. MX2013000002A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2001/041444 WO2002010831A2 (en) 2000-07-27 2001-07-27 Differential interferometric scanning near-field confocal microscopy
US35732110P 2010-06-22 2010-06-22

Publications (1)

Publication Number Publication Date
MX2013000002A true MX2013000002A (es) 2013-04-29

Family

ID=45372075

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000002A MX2013000002A (es) 2001-07-27 2001-07-27 Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.

Country Status (16)

Country Link
US (1) US20120107385A1 (es)
EP (1) EP2585010A4 (es)
JP (1) JP2013534923A (es)
KR (1) KR20130118296A (es)
CN (1) CN103153245A (es)
AR (1) AR084700A1 (es)
AU (1) AU2011270995A1 (es)
CA (1) CA2803872A1 (es)
CL (2) CL2012003658A1 (es)
EA (1) EA201291299A1 (es)
MX (1) MX2013000002A (es)
PE (1) PE20130639A1 (es)
SG (2) SG10201504871PA (es)
TW (1) TW201212910A (es)
WO (1) WO2011163356A2 (es)
ZA (1) ZA201209757B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220061253A (ko) 2014-06-26 2022-05-12 타리스 바이오메디컬 엘엘씨 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
EP3829582A4 (en) * 2018-08-01 2022-04-27 TARIS Biomedical LLC METHOD OF TREATMENT OF OVERACTIVE BLADDER USING TROSPIUM
KR20220146361A (ko) * 2021-04-23 2022-11-01 김승범 과민성 방광 치료 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
AU748653B2 (en) * 1998-05-01 2002-06-06 John F. Cline Method for injection molding manufacture of controlled release devices
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
US8226972B2 (en) * 2001-12-20 2012-07-24 Femmepharma Holding Company, Inc. Vaginal delivery of drugs
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
WO2005004837A1 (en) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
CA2596933A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof

Also Published As

Publication number Publication date
PE20130639A1 (es) 2013-06-15
SG10201504871PA (en) 2015-07-30
AR084700A1 (es) 2013-06-05
JP2013534923A (ja) 2013-09-09
US20120107385A1 (en) 2012-05-03
CL2013003488A1 (es) 2014-08-08
EP2585010A4 (en) 2014-10-01
ZA201209757B (en) 2015-06-24
KR20130118296A (ko) 2013-10-29
SG186815A1 (en) 2013-02-28
WO2011163356A2 (en) 2011-12-29
EA201291299A1 (ru) 2013-09-30
CL2012003658A1 (es) 2014-02-14
CN103153245A (zh) 2013-06-12
TW201212910A (en) 2012-04-01
AU2011270995A1 (en) 2013-01-10
EP2585010A2 (en) 2013-05-01
WO2011163356A3 (en) 2012-03-22
CA2803872A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
WO2002010831A3 (en) Differential interferometric scanning near-field confocal microscopy
CN107941763B (zh) 一种共轴三维受激辐射损耗超分辨显微成像方法和装置
US6567584B2 (en) Illumination system for one-dimensional spatial light modulators employing multiple light sources
TW550377B (en) Apparatus for wave-front detection
US20100202043A1 (en) Slit-scanning confocal microscope
JP6996048B2 (ja) 広視野高分解能顕微鏡
JP6118441B2 (ja) 適応光学網膜結像装置及び方法
US6958470B2 (en) Scanning microscope with a detector and light source for exciting an energy state in a specimen and module for a scanning microscope
US6555826B2 (en) Apparatus for illuminating a specimen and confocal fluorescence scanning microscope
JP5167468B2 (ja) レーザ走査型顕微鏡
CN109477970A (zh) 激光线照射
KR960042228A (ko) 포토리도그래피 기법에서 사용하는 혼성(hybrid) 조명 장치
JP2002228934A (ja) 走査型顕微鏡
US8789950B2 (en) Confocal line-scanning ophthalmoscope
JPH05509178A (ja) 顕微鏡のための共焦点画像システム
US10989920B2 (en) Optical system
CN104749901A (zh) 一种调焦调平装置
Búzás et al. Biological microscopy with undetected photons
MX2013000002A (es) Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
US6891670B2 (en) Double confocal scanning microscope
US4667109A (en) Alignment device
JP2011064892A (ja) 空間光変調装置、及び、それを備えたレーザ照明装置、レーザ顕微鏡
US20100220336A1 (en) Interferometer
JP2013512469A (ja) ラスタ顕微鏡用の位相フィルタ
KR20230157493A (ko) 고속 거리 측정을 위한 색채 공초점 측정 시스템

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal